Dual modes of antitumor action of an amphiphilic peptide A9K

Biomaterials

Volumn 34, Issue 11, 2013, Pages 2731-2737

  Xu, Hai ^a   Chen, Cui Xia ^a   Hu, Jing ^a   Zhou, Peng ^a   Zeng, Ping ^a   Cao, Chang Hai ^a   Lu, Jian Ren ^b  

^a CHINA UNIVERSITY OF PETROLEUM   (China)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Amphiphilic peptide; Antitumor activity; Biointerface; Cell apoptosis; Membrane permeability; Mitochondrial dysfunction

Indexed keywords

AMPHIPHILICS; ANTI-TUMOR ACTIVITIES; BIOINTERFACES; CELL APOPTOSIS; MEMBRANE PERMEABILITY; MITOCHONDRIAL DYSFUNCTION;

CELL CULTURE; CELL DEATH; CELL MEMBRANES; FLUORESCENCE MICROSCOPY; MITOCHONDRIA; PEPTIDES; TRANSCRIPTION;

DRUG PRODUCTS;

AMPHOPHILE; ANTINEOPLASTIC AGENT; F ACTIN; MYC PROTEIN; PEPTIDE A9K; PROTEIN BCL 2; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL MEMBRANE; CELL STRAIN 3T3; CELL STRAIN COS7; CELL STRAIN HL 60; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; DRUG PENETRATION; DRUG SELECTIVITY; ERYTHROCYTE; FEMALE; FIBROBLAST; FLUORESCENCE MICROSCOPY; HELA CELL; HUMAN; HUMAN CELL; MAMMAL CELL; MEMBRANE DAMAGE; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SCANNING ELECTRON MICROSCOPY; UTERINE CERVIX CARCINOMA;

ACTINS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COS CELLS; DOWN-REGULATION; ERYTHROCYTES; GENES, MYC; HELA CELLS; HL-60 CELLS; HUMANS; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; NIH 3T3 CELLS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURFACE-ACTIVE AGENTS; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 84873099755     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.12.039     Document Type: Article

References (39)

1. Hoskin D.W., Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 2008, 1778:357-375.
2. Schweizer F. Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol 2009, 625:190-194.
3. Hancock R.E.W., Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006, 24:1551-1557.
4. http://aps.unmc.edu/AP/.
5. Lehmann J., Retz M., Sidhu S.S., Suttmann H., Sell M., Paulsen F. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. Eur Urol 2006, 50:141-147.
6. Mader J.S., Richardson A., Salsman J., Top D., de Antueno R., Duncan R., et al. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria. Exp Cell Res 2007, 313:2634-2650.
7. Gifford J.L., Hunter H.N., Vogel H.J. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci 2005, 62:2588-2598.
8. Chan Y.R., Gallo R.L. PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130Cas. J Biol Chem 1998, 273:28978-28985.
9. Sharma S.V. Melittin-induced hyperactivation of phospholipase A2 activity and calcium influx in ras-transformed cells. Oncogene 1993, 8:939-947.
10. Mader J.S., Hoskin D.W. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 2006, 15:933-946.
11. Riedl S., Zweytick D., Lohner K. Membrane-active host defense peptides-challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 2011, 164:766-781.
12. Dathe M., Nikolenko H., Meyer J., Beyermann M., Bienert M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett 2001, 501:146-150.
13. Porter E.A., Weisblum B., Gellman S.H. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial β-peptides. J Am Chem Soc 2002, 124:7324-7330.
14. Asthana N., Yadav S.P., Ghosh J.K. Dissection of antibacterial and toxic activity of melittin. J Biol Chem 2004, 279:55042-55050.
15. Laverty G., McLaughlin M., Shaw C., Gorman S.P., Gilmore B.F. Antimicrobial activity of short, synthetic cationic lipopeptides. Chem Biol Drug Des 2010, 75:563-569.
16. Hu J., Chen C., Zhang S., Zhao X., Xu H., Zhao X., et al. Designed antimicrobial and antitumor peptides with high selectivity. Biomacromolecules 2011, 12:3839-3843.
17. Papo N., Shahar M., Eisenbach L., Shai Y. A novel lytic peptide composed of D, L-amino acids selectively kills cancer cells in culture and in mice. J Biol Chem 2003, 278:21018-21023.
18. Cruciani R.A., Barker J.L., Zasloff M., Chen H.C., Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci U S A 1991, 88:3792-3796.
19. Merrifield R.B., Juvvadi P., Anderu D., Ubach J., Boman A., Boman H.G. Retro and retroenantio analogs of cecropin-melittin hybrids. Proc Natl Acad Sci U S A 1995, 92:3449-3453.
20. Risso A., Braidot E., Sordano M.C., Vianello A., Macri F., Skerlavaj B., et al. BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol Cell Biol 2002, 22:1926-1935.
21. Papo N., Seger D., Makovitzki A., Kalchenko V., Eshhar Z., Degani H., et al. Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res 2006, 66:5371-5378.
22. Makovitzki A., Fink A., Shai Y. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides. Cancer Res 2009, 69:3458-3463.
23. Risso A., Zanetti M., Gennaro R. Cytotoxicity and apoptosis mediated by two peptides of innate immunity. Cell Immunol 1998, 189:107-115.
24. Tanaka K., Fujimoto Y., Suzuki M., Suzuki Y., Ohtake T., Saito H., et al. PI3-kinase p85α is a target molecule of proline-rich antimicrobial peptide to suppress proliferation of ras-transformed cells. Jpn J Cancer Res 2001, 92:959-967.
25. Dobrzynska J., Szachowicz-Petelska B., Sulkowski S., Figaszewski Z. Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol Cell Biochem 2005, 276:113-119.
26. Dennis J.W. N-linked oligosaccharide processing and tumor cell biology. Semin Cancer Biol 1991, 2:411-420.
27. Chen C., Pan F., Zhang S., Hu J., Cao M., Wang J., et al. Antibacterial activities of short designer peptides: a link between propensity for nanostructuring and capacity for membrane destabilization. Biomacromolecules 2010, 11:402-411.
28. Chen C., Hu J., Zhang S., Zhou P., Zhao X., Xu H., et al. Molecular mechanisms of antibacterial and antitumor actions of designed surfactant-like peptides. Biomaterials 2012, 33:592-603.
29. Tosteson M.T., Holmes S.J., Razin M., Tosteson D.C. Melittin lysis of red cells. J Membr Biol 1985, 87:35-44.
30. Baker M.A., Maloy W.L., Zasloff M., Jacob L.S. Anticancer efficacy of magainin2 and analogue peptides. Cancer Res 1993, 53:3052-3057.
31. Bell G., Gouyon P. Arming the enemy: the evolution of resistance to self-proteins. Microbiology 2003, 149(Pt 6):1367-1375.
32. Kosuge M., Takeuchi T., Nakase I., Jones A.T., Futaki S. Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug Chem 2008, 19:656-664.
33. Gourlay C.W., Ayscough K.R. Role for actin in aging and apoptosis. Biochem Soc Trans 2005, 33:1260-1264.
34. Okada T., Otani H., Wu Y., Kyoi S., Enoki C., Fujiwara H., et al. Role of F-actin organization in p38 MAP kinase-mediated apoptosis and necrosis in neonatal rat cardiomyocytes subjected to simulated ischemia and reoxygenation. Am J Physiol Heart Circ Physiol 2005, 289:H2310-H2318.
35. Reers M., Smiley S., Mottola-Hartshorn C., Chen A., Lin M., Chen L. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 1995, 260:406-417.
36. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., et al. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-1132.
37. Chipuk J.E., Green D.R. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?. Trends Cell Biol 2008, 18:157-164.
38. Li R., Cheng Y., Gao C. Enhancing radiosensitivity of Hela cells by combining transfection of bcl-2 c-myc ASODNs. Bull Cancer 2006, 93:E119-E125.
39. Hamamoto K., Kida Y., Zhang Y., Shimizu T., Kuwano K. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol Immunol 2002, 46:741-749.